Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 23andMe is back: FDA allows marketing of genetic health risk tests
23andMe is back: FDA allows marketing of genetic health risk tests
23andMe is back: FDA allows marketing of genetic health risk tests
Submitted by
admin
on April 22, 2017 - 1:10pm
Source:
Mass Device
News Tags:
FDA
23andMe
diagnostics
Headline:
23andMe is back: FDA allows marketing of genetic health risk tests
Do Not Allow Advertisers to Use My Personal information
